Research advances in integrated traditional Chinese and Western medicine therapy for liver cirrhosis
10.3969/j.issn.1001-5256.2022.09.001
- VernacularTitle:肝硬化中西医结合治疗的研究进展
- Author:
Shili JIANG
1
;
Ping LIU
1
Author Information
1. Institute of Liver Disease, Shanghai Academy of Traditional Chinese Medicine, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
- Publication Type:Editorial
- Keywords:
Liver Cirrhosis;
Therapeutics;
TCM WM Therapy
- From:
Journal of Clinical Hepatology
2022;38(9):1953-1955
- CountryChina
- Language:Chinese
-
Abstract:
The combination of traditional Chinese medicine and Western medicine is an important approach to improve the treatment outcome of liver cirrhosis. Long-term diagnosis and treatment practice and clinical studies of the prevention and treatment of chronic hepatitis B cirrhosis have shown that antiviral drugs targeting the cause of the disease combined with anti-liver fibrosis traditional Chinese medicine can significantly improve the reversal rate of liver fibrosis and cirrhosis, and anti-liver fibrosis therapy can reduce the incidence rates of esophagogastric variceal bleeding and hepatocellular carcinoma in cirrhotic patients and improve the 5-year survival rate of patients with decompensated liver cirrhosis. It is necessary to conduct in-depth studies to clarify the target and mechanism of action of the main effective constituents of compound traditional Chinese medicine, strengthen the research on drug quality control standards, and obtain more high-quality evidence for clinical efficacy, so as to effectively promote the development of integrated traditional Chinese and Western medicine therapy for liver cirrhosis.
